index - Myopathies inflammatoires & thérapies innovantes ciblées Accéder directement au contenu

Dernières publications

Chiffres clés

121 Publications avec texte intégral

Open Access

53 %

Mots clés

Animals Anti-Mi2 AAV Anti-drug antibodies Adverse drug reactions Auto-immunité Agalsidase Anticorps spécifique des myosites Deep immune profiling Antiphospholipid syndrome Immune checkpoint inhibitors Anti-MDA5 autoantibodies Idiopathic inflammatory myopathies Gene therapy Anti‐mitochondrial antibodies Amyotrophic lateral sclerosis Aldosterone B-lymphocyte Inborn errors of metabolism Myocarditis Antisynthétase AAV vectors Aldostérone Case reports CD8+ T-bet+ cells Analyses multidimensionnelles Data integration Inflammatory myopathy Cytokines Immunotherapy Acute Kidney Injury/epidemiology/etiology Skeletal muscle Lysosomal storage diseases Antibodies Sphingosine-1-phosphate Arthritis Antibody responses IBM Bioelectrical impedance analysis Adolescence Acid-alpha-glucosidase DM Dermatomyositis Adeno-associated vector Auto-antibodies CD8+T cells Outcome measures Anticorps anti-agalsidase Mass cytometry Antisynthetase Muscle Assisted communication devices Fabry disease Abnormal movement AAV humoral immunity Biomarqueurs AAV antibody Anti-agalsidase antibodies Adjudication Female Anémie hémolytique Adeno-associated virus vector Cancer Inflammation Myositis and muscle disease Autoantibodies Myopathy IMNM Inclusion body myositis Prognosis Interstitial lung disease Aged Active Machine learning Systems biology Amyotrophy Multidisciplinarity B cell homeostasis Anti-IgE IgG Middle Aged Humans COVID-19 Biomarker Autoimmune diseases Dependovirus/genetics/immunology Adeno-associated virus Interferon Autoantibody Anti-synthetase syndrome Autoimmunity Anti-interleukin-6 AAV vector Biomarkers Antisynthetase syndrome Polymyositis Auto‐antibodies Adult Myositis Biopsy Male